Bill > HR727

This bill, known as the "Prohibiting Abortion Industry's Lucrative Loopholes Act," seeks to amend the Public Health Service Act by expanding the definition of "valuable consideration" in relation to human fetal tissue transactions. The bill broadens the existing legal definition to include a wide range of potential financial exchanges, such as direct payments, debts, gifts, reduced fees, canceled loans, and any other transfers of value. Specifically, the bill adds new provisions that would categorize as "valuable consideration" any payments related to transportation, processing, preservation, quality control, or storage of human fetal tissue. The effect of this expanded definition is to more comprehensively prohibit any form of financial compensation or benefit associated with the transfer or handling of human fetal tissue, potentially making such transactions more difficult or legally risky. By explicitly listing multiple types of potential financial exchanges, the bill aims to close what its proponents likely see as existing loopholes in current law regarding fetal tissue transactions.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/727/all-info